Verum Partners LLC

Position in ABBV — AbbVie Inc.

CIK 1958984 CHARLOTTE, NC

Position in ABBV

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$969,065

+$224,597 QoQ

Shares Held

3,851

+12.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.86%

of 13F equity value

Holder Rank

#2,573

of 4,153 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Verum Partners LLC holds $8,397,946 across 6 Drug Manufacturers - General names. ABBV ranks #3 (11.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,715	$4,455,882
2	JNJ	Johnson & Johnson	6,156	$1,563,439
3	ABBV	AbbVie Inc. This page	3,851	$969,065
4	MRK	Merck & Co., Inc.	5,758	$739,903
5	AMGN	Amgen Inc	1,290	$467,134
6	GILD	Gilead Sciences, Inc.	1,603	$202,523

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$969,065	3,851	+12.5%	Shares	Sole	2026-07-22
2026-03-31	$744,468	3,423	+5.0%	Shares	Sole	2026-04-15
2025-12-31	$744,648	3,259	-4.6%	Shares	Sole	2026-01-14
2025-09-30	$790,709	3,415	-1.4%	Shares	Sole	2025-11-12
2025-06-30	$643,173	3,465	+24.0%	Shares	Sole	2025-07-15
2025-03-31	$585,608	2,795	-3.1%	Shares	Sole	2025-04-11
2024-12-31	$512,486	2,884	-2.8%	Shares	Sole	2025-01-17
2024-09-30	$585,725	2,966	+6.7%	Shares	Sole	2024-10-16
2024-06-30	$476,997	2,781	-0.1%	Shares	Sole	2024-07-15
2024-03-31	$506,784	2,783	-4.0%	Shares	Sole	2024-04-18
2023-12-31	$449,103	2,898	-1.1%	Shares	Sole	2024-01-18
2023-09-30	$436,894	2,931	+53.1%	Shares	Sole	2023-10-10
2023-06-30	$257,873	1,914	—	Shares	Sole	2023-07-24
No filing history on record for this holder in this stock.